CD27 and neoplasm: Interestingly, CD27 on malignant B cells triggers CD70 reverse signaling in NK cells, resulting in increased numbers of tumor-infiltrating activated NK cells and prolonged survival of CD27-expressing lymphoma-bearing mice [99].